&nbsp;

Dec 1969

Drug

AFAtinib

Other Name(s): Giotrif®

Quick Link(s):

Dec 1969

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Jul 2023

Drug

ponatinib

Other Name(s): Iclusig®

Quick Link(s):

Sep 2020

Drug

palbociclib

Other Name(s): Ibrance™

Quick Link(s):

Dec 1969

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Dec 1969

Regimen

AXIT

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

Exceptional Access Program

aXitinib - For second or third line treatment of advanced renal cell carcinoma, according to clinical criteria

Drugs Used:

aXitinib

Quick Link(s):

Regimen Monograph

Regimen

AFAT

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

AFAtinib - For first-line monotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC), according to specific criteria

Drugs Used:

AFAtinib

Quick Link(s):

Regimen Monograph

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia, according to specific clinical criteria

Drugs Used:

ponatinib

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), according to specific clinical criteria

Drugs Used:

ponatinib

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of non-small cell lung cancer, according to specific criteria

Drugs Used:

alectinib

Quick Link(s):

Regimen Monograph

Regimen

ATRA(IND)

Cancer Type:

Hematologic,

Leukemia - Acute Promyelocytic (APL)

Intent: Palliative, Curative

Funding:

Exceptional Access Program

tretinoin (ATRA)

Drugs Used:

tretinoin (ATRA)